| Mar 30, 2011
| 12:16 PM
People who don't believe their pain medicine will work can actually reduce or even cancel out the effectiveness of the drug, and images of their brains show how they are doing it, scientists report.
Researchers from Britain and Germany used brain scans...
| Oct 28, 2010
| 7:23 PM
Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues.
He found several doctors who had potentially compromising...
| Jul 13, 2010
| 6:37 AM
Hearings begin today on whether the drug Avandia should stay on the market.
Ahead of the hearings, FDA scientists have blasted a study by drug maker GlaxoSmithKline used to defend the safety of the once high-riding diabetes drug, which fell out of favor...
| Jul 13, 2010
| 8:26 AM
GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said.
Glaxo, the U.K.'s biggest drugmaker, agreed to...
| Jun 30, 2010
| 2:11 PM
The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.
So, when is a drug too risky to stay on the market?
| Jun 29, 2010
The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
| Jul 14, 2010
| 12:54 PM
U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban.
The 33-member panel of outside experts convened by the...
| Jul 15, 2010
Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
| Aug 19, 2010
The safety of most diabetes drugs are time-tested — insulin was discovered in the early 1920s, and two of the other most commonly prescribed, metformin and sulfonylurea, have been around since the 1950s.
Avandia is different. The drug landed with a...
| Aug 19, 2010
Sentenced On Charges Of Falsified Records Of Clinical Trials Involving Children.
DR. MARIA CARMEN PALAZZO, age 58, pled guilty in federal court today before U. S. District Judge Mary Ann Vial Lemmon to fifteen (15) counts of failing to prepare and...
| Feb 7, 2011
| 8:41 PM
WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack.
The Food and Drug Administration...
| Feb 18, 2011
| 8:03 AM
The Bill and Melinda Gates Foundation is helping partners in China improve child vaccines, roll out faster TB detection kits and make higher-yielding rice which it hopes can be used later in other parts of the world.
Ray Yip, the foundation's chief...